Author

C. Grundner

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:bacteria (other)· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Frando· 2 shared V. Boradia· 2 shared C. D. Torrice· 1 shared C. R. M. Asquith· 1 shared D. J. Crona· 1 shared D. R. Sherman· 1 shared J. M. Jacobs· 1 shared L. Day· 1 shared

Activity by Year

2019-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

A. Frando

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Calcium transport by the Mycobacterium tuberculosis PE15/PPE20 proteins

V. Boradia, A. Frando, C. Grundner

The paper identifies PE15/PPE20 as a Ca2+-binding complex in Mycobacterium tuberculosis that selectively imports Ca2+ and regulates biofilm formation and ATP consumption.

bioRxiv · May 30, 2022Microbiology

The Mycobacterium tuberculosis protein O-phosphorylation landscape

A. Frando, V. Boradia, M. Gritsenko, M.-C. Beltejar, L. Day, D. R. Sherman, S. Ma, J. M. Jacobs, C. Grundner

This study identifies the O-phosphorylation landscape in Mycobacterium tuberculosis, revealing its widespread impact on the proteome and gene regulation.

bioRxiv · Feb 17, 2022Microbiology

Anti-tubercular activity of novel 4-anilinoquinolines and 4-anilinoquinazolines

C. R. M. Asquith, N. Fleck, C. D. Torrice, D. J. Crona, C. Grundner, W. J. Zuercher

The paper identifies novel anti-tubercular compounds from 4-anilinoquinolines and 4-anilinoquinazolines with high potency and low toxicity.

bioRxiv · Jun 18, 2019Pharmacology & Toxicology